nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—Renal impairment—Metformin—metabolic syndrome X	0.00907	0.0617	CcSEcCtD
Tolvaptan—Hypoglycaemia—Metformin—metabolic syndrome X	0.00885	0.0602	CcSEcCtD
Tolvaptan—Dehydration—Metformin—metabolic syndrome X	0.00803	0.0546	CcSEcCtD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00781	0.00918	CbGpPWpGaD
Tolvaptan—Breast disorder—Metformin—metabolic syndrome X	0.0078	0.0531	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00721	0.00847	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00715	0.00841	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.00714	0.0084	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL5—metabolic syndrome X	0.00713	0.00839	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL5—metabolic syndrome X	0.00708	0.00833	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00688	0.00808	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00683	0.00803	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00672	0.0079	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00667	0.00785	CbGpPWpGaD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00666	0.00783	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00652	0.00766	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00647	0.00761	CbGpPWpGaD
Tolvaptan—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00633	0.00744	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00617	0.00726	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00613	0.00721	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—AGT—metabolic syndrome X	0.00604	0.0071	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—AGT—metabolic syndrome X	0.00597	0.00701	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00595	0.007	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—AGT—metabolic syndrome X	0.00593	0.00696	CbGpPWpGaD
Tolvaptan—Connective tissue disorder—Metformin—metabolic syndrome X	0.00587	0.0399	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.00565	0.00664	CbGpPWpGaD
Tolvaptan—Cardiac disorder—Metformin—metabolic syndrome X	0.00554	0.0377	CcSEcCtD
Tolvaptan—Angiopathy—Metformin—metabolic syndrome X	0.00542	0.0368	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.00541	0.00635	CbGpPWpGaD
Tolvaptan—Immune system disorder—Metformin—metabolic syndrome X	0.00539	0.0367	CcSEcCtD
Tolvaptan—Mediastinal disorder—Metformin—metabolic syndrome X	0.00538	0.0366	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00524	0.00616	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.0052	0.00611	CbGpPWpGaD
Tolvaptan—Malnutrition—Metformin—metabolic syndrome X	0.0052	0.0354	CcSEcCtD
Tolvaptan—Dysgeusia—Metformin—metabolic syndrome X	0.00509	0.0346	CcSEcCtD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—GCK—metabolic syndrome X	0.00504	0.00592	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GHRL—metabolic syndrome X	0.00496	0.00584	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GHRL—metabolic syndrome X	0.00493	0.00579	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL2—metabolic syndrome X	0.00492	0.00578	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL2—metabolic syndrome X	0.00488	0.00574	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Metformin—metabolic syndrome X	0.00482	0.0328	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00479	0.00562	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00475	0.00558	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CNR1—metabolic syndrome X	0.0047	0.00553	CbGpPWpGaD
Tolvaptan—Malaise—Metformin—metabolic syndrome X	0.00469	0.0319	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CNR1—metabolic syndrome X	0.00467	0.00549	CbGpPWpGaD
Tolvaptan—Syncope—Metformin—metabolic syndrome X	0.00466	0.0317	CcSEcCtD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00462	0.00543	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Metformin—metabolic syndrome X	0.00457	0.0311	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.00449	0.00527	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0044	0.0299	CcSEcCtD
Tolvaptan—Discomfort—Metformin—metabolic syndrome X	0.00437	0.0297	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.00433	0.00509	CbGpPWpGaD
Tolvaptan—Shock—Metformin—metabolic syndrome X	0.00417	0.0284	CcSEcCtD
Tolvaptan—Nervous system disorder—Metformin—metabolic syndrome X	0.00416	0.0283	CcSEcCtD
Tolvaptan—ABCB1—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.00414	0.00486	CbGpPWpGaD
Tolvaptan—Skin disorder—Metformin—metabolic syndrome X	0.00412	0.028	CcSEcCtD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.0041	0.00482	CbGpPWpGaD
Tolvaptan—Anorexia—Metformin—metabolic syndrome X	0.00404	0.0275	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.004	0.00471	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00397	0.00467	CbGpPWpGaD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00382	0.00448	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.0038	0.00447	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00377	0.00443	CbGpPWpGaD
Tolvaptan—Decreased appetite—Metformin—metabolic syndrome X	0.00369	0.0251	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00366	0.0249	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL5—metabolic syndrome X	0.00364	0.00428	CbGpPWpGaD
Tolvaptan—Constipation—Metformin—metabolic syndrome X	0.00363	0.0247	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CCL5—metabolic syndrome X	0.00362	0.00425	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Metformin—metabolic syndrome X	0.0035	0.0238	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.00349	0.0041	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00345	0.00406	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00343	0.00403	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.0033	0.00388	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00327	0.00385	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.00316	0.00372	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00312	0.00366	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—AGT—metabolic syndrome X	0.00305	0.00358	CbGpPWpGaD
Tolvaptan—Asthenia—Metformin—metabolic syndrome X	0.00304	0.0207	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—AGT—metabolic syndrome X	0.00303	0.00356	CbGpPWpGaD
Tolvaptan—Pruritus—Metformin—metabolic syndrome X	0.003	0.0204	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00296	0.00348	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00294	0.00345	CbGpPWpGaD
Tolvaptan—Diarrhoea—Metformin—metabolic syndrome X	0.0029	0.0197	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.00287	0.00337	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00284	0.00334	CbGpPWpGaD
Tolvaptan—Dizziness—Metformin—metabolic syndrome X	0.00281	0.0191	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00281	0.0033	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00279	0.00327	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00278	0.00327	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00269	0.00316	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00267	0.00314	CbGpPWpGaD
Tolvaptan—Headache—Metformin—metabolic syndrome X	0.00266	0.0181	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00266	0.00312	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00264	0.0031	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—LEP—metabolic syndrome X	0.00258	0.00303	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00255	0.00299	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GHRL—metabolic syndrome X	0.00253	0.00297	CbGpPWpGaD
Tolvaptan—Nausea—Metformin—metabolic syndrome X	0.00252	0.0171	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL2—metabolic syndrome X	0.00251	0.00295	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL2—metabolic syndrome X	0.00249	0.00293	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.00242	0.00284	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00241	0.00284	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CNR1—metabolic syndrome X	0.0024	0.00282	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00235	0.00276	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.00228	0.00268	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.00227	0.00267	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HDAC3—metabolic syndrome X	0.00226	0.00266	CbGpPWpGaD
Tolvaptan—Vismodegib—ALB—metabolic syndrome X	0.00217	1	CrCbGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00206	0.00242	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00204	0.0024	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00204	0.0024	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00202	0.00238	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	0.00202	0.00238	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.00199	0.00233	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RBP4—metabolic syndrome X	0.00199	0.00233	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00198	0.00232	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TRIB3—metabolic syndrome X	0.00197	0.00232	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RBP4—metabolic syndrome X	0.00197	0.00232	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL5—metabolic syndrome X	0.00187	0.0022	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00186	0.00219	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL5—metabolic syndrome X	0.00186	0.00218	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00185	0.00217	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.0018	0.00211	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOC3—metabolic syndrome X	0.00176	0.00207	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOC3—metabolic syndrome X	0.00175	0.00205	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.00172	0.00202	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AGT—metabolic syndrome X	0.00171	0.00201	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.00159	0.00187	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2C—metabolic syndrome X	0.00158	0.00185	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.00157	0.00185	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AGT—metabolic syndrome X	0.00156	0.00184	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AGT—metabolic syndrome X	0.00155	0.00183	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CYBA—metabolic syndrome X	0.00154	0.00181	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CYBA—metabolic syndrome X	0.00153	0.00179	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GHRL—metabolic syndrome X	0.00151	0.00177	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GHRL—metabolic syndrome X	0.00149	0.00176	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CNR1—metabolic syndrome X	0.00143	0.00168	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CNR1—metabolic syndrome X	0.00142	0.00166	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.0014	0.00164	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.00134	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00129	0.00151	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL2—metabolic syndrome X	0.00128	0.0015	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF2—metabolic syndrome X	0.00117	0.00137	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF2—metabolic syndrome X	0.00116	0.00136	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOB—metabolic syndrome X	0.00113	0.00133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOB—metabolic syndrome X	0.00112	0.00132	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	0.00111	0.0013	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL5—metabolic syndrome X	0.0011	0.0013	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.0011	0.00129	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL5—metabolic syndrome X	0.0011	0.00129	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00109	0.00128	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.00109	0.00128	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LPL—metabolic syndrome X	0.00108	0.00127	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.00108	0.00126	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LPL—metabolic syndrome X	0.00107	0.00126	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	0.00103	0.00121	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AGT—metabolic syndrome X	0.000924	0.00109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AGT—metabolic syndrome X	0.000918	0.00108	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.00091	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LEP—metabolic syndrome X	0.000905	0.00106	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—metabolic syndrome X	0.000905	0.00106	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LEP—metabolic syndrome X	0.000899	0.00106	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—metabolic syndrome X	0.000899	0.00106	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOA1—metabolic syndrome X	0.000895	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOA1—metabolic syndrome X	0.000889	0.00104	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	0.000887	0.00104	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FMO3—metabolic syndrome X	0.000877	0.00103	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000855	0.001	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000825	0.000969	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IRS1—metabolic syndrome X	0.000808	0.000949	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IRS1—metabolic syndrome X	0.000802	0.000943	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EPHX2—metabolic syndrome X	0.000782	0.000919	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	0.000782	0.000919	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INS—metabolic syndrome X	0.000774	0.000909	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INS—metabolic syndrome X	0.000768	0.000903	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—metabolic syndrome X	0.000761	0.000895	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—metabolic syndrome X	0.000756	0.000888	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000755	0.000887	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—metabolic syndrome X	0.000748	0.000879	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—metabolic syndrome X	0.000743	0.000873	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—G6PC2—metabolic syndrome X	0.000735	0.000864	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000711	0.000835	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000705	0.000829	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—metabolic syndrome X	0.000678	0.000797	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—metabolic syndrome X	0.000673	0.000792	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000665	0.000781	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FABP4—metabolic syndrome X	0.000625	0.000735	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	0.000593	0.000697	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000581	0.000683	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000577	0.000678	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—metabolic syndrome X	0.000572	0.000673	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—metabolic syndrome X	0.000568	0.000668	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000546	0.000642	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000546	0.000641	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000541	0.000635	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—G6PD—metabolic syndrome X	0.000528	0.000621	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000528	0.00062	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—metabolic syndrome X	0.000524	0.000616	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HDAC3—metabolic syndrome X	0.000516	0.000606	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000509	0.000599	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCKR—metabolic syndrome X	0.000504	0.000592	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPA—metabolic syndrome X	0.000504	0.000592	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	0.000488	0.000574	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA5—metabolic syndrome X	0.000483	0.000568	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000482	0.000566	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000482	0.000566	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000461	0.000542	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000453	0.000533	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TRIB3—metabolic syndrome X	0.000449	0.000528	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000449	0.000527	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—metabolic syndrome X	0.000445	0.000523	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000432	0.000508	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAMPT—metabolic syndrome X	0.000403	0.000474	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCK—metabolic syndrome X	0.0004	0.000471	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LIPC—metabolic syndrome X	0.0004	0.000471	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOC3—metabolic syndrome X	0.000398	0.000468	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CETP—metabolic syndrome X	0.000386	0.000454	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000385	0.000453	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000379	0.000446	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SCARB1—metabolic syndrome X	0.00037	0.000435	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000365	0.000429	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SREBF1—metabolic syndrome X	0.000359	0.000422	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMGCR—metabolic syndrome X	0.000349	0.000411	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT2—metabolic syndrome X	0.000349	0.000411	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000342	0.000403	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—metabolic syndrome X	0.000338	0.000397	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—metabolic syndrome X	0.000336	0.000394	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.000325	0.000383	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000318	0.000373	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—metabolic syndrome X	0.000312	0.000367	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCA1—metabolic syndrome X	0.000311	0.000366	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	0.000311	0.000366	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCKR—metabolic syndrome X	0.000311	0.000365	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPA—metabolic syndrome X	0.000311	0.000365	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—metabolic syndrome X	0.00031	0.000364	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT1—metabolic syndrome X	0.000302	0.000354	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GGT1—metabolic syndrome X	0.000302	0.000354	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	0.000301	0.000353	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA5—metabolic syndrome X	0.000298	0.00035	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	0.000277	0.000325	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOB—metabolic syndrome X	0.000256	0.000301	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	0.000249	0.000293	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	0.000248	0.000292	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LIPC—metabolic syndrome X	0.000247	0.00029	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCK—metabolic syndrome X	0.000247	0.00029	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOC3—metabolic syndrome X	0.000245	0.000288	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPL—metabolic syndrome X	0.000244	0.000287	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CETP—metabolic syndrome X	0.000238	0.00028	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD36—metabolic syndrome X	0.000232	0.000273	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	0.000228	0.000268	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	0.000221	0.00026	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARA—metabolic syndrome X	0.000216	0.000254	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	0.000215	0.000253	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT2—metabolic syndrome X	0.000215	0.000253	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGT—metabolic syndrome X	0.000209	0.000246	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—metabolic syndrome X	0.000205	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA1—metabolic syndrome X	0.000202	0.000238	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	0.000192	0.000225	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	0.000192	0.000225	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT1—metabolic syndrome X	0.000186	0.000218	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GGT1—metabolic syndrome X	0.000186	0.000218	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—metabolic syndrome X	0.000178	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INS—metabolic syndrome X	0.000175	0.000206	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—metabolic syndrome X	0.00016	0.000189	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOB—metabolic syndrome X	0.000158	0.000185	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—metabolic syndrome X	0.000153	0.00018	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	0.000153	0.00018	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPL—metabolic syndrome X	0.000151	0.000177	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD36—metabolic syndrome X	0.000143	0.000168	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—metabolic syndrome X	0.00014	0.000165	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARA—metabolic syndrome X	0.000133	0.000156	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGT—metabolic syndrome X	0.000129	0.000151	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—metabolic syndrome X	0.000126	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA1—metabolic syndrome X	0.000125	0.000147	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—metabolic syndrome X	0.00011	0.000129	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INS—metabolic syndrome X	0.000108	0.000127	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—metabolic syndrome X	9.88e-05	0.000116	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—metabolic syndrome X	9.45e-05	0.000111	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	8.65e-05	0.000102	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—metabolic syndrome X	7.05e-05	8.29e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—metabolic syndrome X	4.35e-05	5.11e-05	CbGpPWpGaD
